TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2,298 Cr | ₹-2,780 Cr | ₹77 Cr | ₹-1,781 Cr | ₹-1,651 Cr |
What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2,298 Cr |
| Mar2024 | ₹-2,780 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹-1,781 Cr |
| Mar2021 | ₹-1,651 Cr |
How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2,298 Cr | Negative | |
| Mar2024 | ₹-2,780 Cr | Negative | |
| Mar2023 | ₹77 Cr | Positive | |
| Mar2022 | ₹-1,781 Cr | Negative | |
| Mar2021 | ₹-1,651 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹132,888.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
| MANKIND PHARMA | ₹86,802.6 Cr | -1.3% | -1.8% | -19.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.1% |
5.5% |
25.3% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses